L-Thyroxin 75 1 A Pharma

Levothyroxine Sodium, the active ingredient in L-Thyroxin 75 1 A Pharma, is a thyroid hormone presented as a 75 µg tablet for oral use. It replaces deficient thyroid hormone and is employed to treat hypothyroidism, thyroid hormone deficiency, and related disorders in adults and children.

GNH USA supplies L-Thyroxin 75 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels aligned to EU regulatory standards, and ensuring product integrity throughout the global supply chain.

Levothyroxine is a synthetic thyroid hormone that acts on the hypothalamic‑pituitary‑thyroid axis to restore normal metabolic function. - Hypothyroidism: restores deficient thyroid hormone levels, improving energy, metabolism and symptom control. - Thyroid hormone replacement therapy after thyroidectomy or radioactive iodine: provides necessary T4 to maintain a euthyroid state. - Goiter associated with thyroid hormone deficiency: reduces gland enlargement by normalizing hormone feedback.

Levothyroxine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Insomnia: difficulty falling or staying asleep. - Palpitations: sensation of rapid or irregular heartbeat. - Weight loss: unintended reduction in body weight. - Heat intolerance: increased sensitivity to warm environments. - Tremor: fine shaking of the hands or limbs.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm that may be life‑threatening. - Angina pectoris: chest pain due to reduced coronary blood flow. - Myocardial infarction: heart attack resulting from blocked coronary arteries. - Severe bone loss (osteoporosis): increased risk of fractures with long‑term overtreatment. - Anaphylactic reaction: rapid onset of allergic symptoms requiring emergency care. - Adrenal crisis: acute insufficiency in patients with concomitant adrenal disease.

When prescribing levothyroxine, clinicians should observe several safety considerations to minimize risk. - Thyroid function monitoring: check serum TSH and free T4 levels after initiation and dose adjustments. - Cardiovascular caution: use lower starting doses in patients with coronary artery disease, heart failure or arrhythmias. - Elderly dosing: initiate therapy with reduced dose and titrate slowly due to increased sensitivity. - Drug interaction awareness: avoid concurrent use of antacids, iron or calcium supplements without spacing. - Pregnancy and lactation: assess risk‑benefit ratio; levothyroxine is generally continued if indicated. - Store at room temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Levothyroxine absorption and activity can be altered by several concomitant medicines, requiring attention to avoid therapeutic failure or toxicity.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levothyroxine absorption. - Iron supplements (ferrous sulfate): decrease oral bioavailability when taken simultaneously. - Rifampin or other enzyme‑inducing antibiotics: increase metabolic clearance, lowering serum levels.

Moderate Interactions (Monitor Closely): - Warfarin: levothyroxine may enhance anticoagulant effect, requiring INR monitoring. - Cholesterol‑lowering statins (e.g., simvastatin): may modestly affect thyroid hormone metabolism. - Oral contraceptives: can increase thyroxine binding proteins, potentially altering dose requirements.